Indium-111 pentetreotide 

Approved Use: Scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors
Dose: 3 mCi (planar), 6 mCi (SPECT) 

Brand Name: Octreoscan™
Manufacturer: Curium
Package Insert
How Supplied: each kit contains:

• Octreoscan™ Reaction Vial (10µg pentetreotide, 2mg gentisic acid, 4.9mg trisodium citrate, 0.37mg citric acid, 10mg inositol) 
• In-111 chloride vial (3.3mCi in 1.1cc) 
• one 25 gauge 5/8" transfer needle (BD, Monoject)  

Calibration: In-111 chloride calibrated:

• Friday @ 18:00 CT (3.3 mCi)
• Sunday calibrated lot is no longer available

Expiration: 

• In-111 chloride vial expires 1 day after calibration
• Reconstituted vial expires 6 hours from time of preparation

Storage: **refrigerate PRIOR to reconstitution**
Availability:

• Ships Sunday and Monday for receipt Monday (4 days pre-cal) and Tuesday (3 days pre-cal)

NDC #: 69945-050-40

In-111 Chloride Vial Activity Chart:
​Calibration:  3.3 mCi on Friday @ 18:00 CT

Monday @ 06:00 CT	10.05 mCi
Tuesday ​@ 06:00 CT	7.85 mCi
Wednesday ​@ 06:00 CT	6.13 mCi
Thursday ​@ 06:00 CT	4.78 mCi
Friday ​@ 06:00 CT	3.74 mCi

Clinical Guidelines:

• ACR–ACNM–SNMMI–SPR Practice Parameter for the Performance of Neuroendocrine Tumor Scintigraphy (2020)
• EANM Practice Guideline/SNMMI Procedure Standard for Radionuclide Imaging of Pheochromocytoma and Paraganglioma (2019)
• ACR-SPR Practice Parameter for the Performance of Tumor Scintigraphy (2015)
• ​SNMMI Procedure Standard for Somatostatin Receptor Scintigraphy 2.0 (2011)